X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - DRUGS.COM - Clinical Trials News - 28/Jun 05:07

Rocket Pharmaceuticals Provides Regulatory Update on Kresladi (marnetegragene autotemcel; marne-cel)

CRANBURY, N.J.--(BUSINESS WIRE)--Jun. 28, 2024-- Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet needs, today...

Articles similaires

Sorry! Image not available at this time

FDA Rejects Rocket's (RCKT) Gene Therapy BLA for Rare Disease

zacks.com - 01/Jul 14:31

Per the FDA, Rocket (RCKT) needs to submit additional manufacturing information on Kresladi gene therapy to secure approval for severe leukocyte...

Sorry! Image not available at this time

Scientists Find Genetic Keys to Immune Disorders

medindia.net - 17:02

Researchers have discovered several rare types of helper T cells linked to immune disorders like multiple sclerosis, rheumatoid arthritis, and...

Sorry! Image not available at this time

Regeneron: Senior Manager, Regulatory Affairs IVD

pharmiweb.com - 24/Jun 00:00

Competitive: Regeneron: Regeneron is advancing its pipeline portfolio using a data-driven human translational approach. The In Vitro Diagnostic (IVD)...

Sorry! Image not available at this time

Peritoneal Cancer Pipeline 2024 | FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight

mountaintoday.in - 26/Jun 19:12

DelveInsight’s, “Peritoneal Cancer Pipeline Insight 2024” report provides comprehensive insights about 55+ companies...

Sorry! Image not available at this time

Biliary Tumor Pipeline 2024 | FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight

mountaintoday.in - 26/Jun 19:24

DelveInsight’s, “Biliary Tumor Pipeline Insight, 2024” report provides comprehensive insights about 50+ companies and...

Sorry! Image not available at this time

Hepatic Tumor Pipeline 2024 | FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight

mountaintoday.in - 26/Jun 19:28

DelveInsight’s, “Hepatic Tumor Pipeline Insight 2024”report provides comprehensive insights about 75+ companies and 75+...

Sorry! Image not available at this time

Regeneron: Senior Manager, Regulatory Affairs IVD

pharmiweb.com - 24/Jun 00:00

Competitive: Regeneron: Regeneron is advancing its pipeline portfolio using a data-driven human translational approach. The In Vitro Diagnostic (IVD)...

Sorry! Image not available at this time

Regeneron: Senior Manager, Regulatory Affairs IVD

pharmiweb.com - 28/Jun 00:00

Competitive: Regeneron: Regeneron is advancing its pipeline portfolio using a data-driven human translational approach. The In Vitro Diagnostic (IVD)...

Sorry! Image not available at this time

Regeneron: Senior Manager, Regulatory Affairs IVD

pharmiweb.com - 02/Jul 00:00

Competitive: Regeneron: Regeneron is advancing its pipeline portfolio using a data-driven human translational approach. The In Vitro Diagnostic (IVD)...

Sorry! Image not available at this time

Padrino Children’s Foundation Announces Co-Authorship of Study on Rare Disease Diagnosis via Clinical Genetic Sequencing (cGS)

caribbeannewsglobal.com - 26/Jun 02:07

TODOS SANTOS, Baja California Sur, Mexico–(BUSINESS WIRE)–The Padrino Children’s Foundation, a non-profit provider of pediatric healthcare...

Les derniers communiqués